AesRx's Acquisition

AesRx was acquired by Baxter International on July 09, 2014.

Aesrx is a biopharmaceutical company developing drugs to target sickle cell disease and inflammatory diseases of the lower intestine, including distal ulcerative colitis, pouchitis and radiation induc…

Articles about AesRx's Acquisition: